• Search
  • Advanced Search

Review

February 23, 2021


Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(4):524-534.

Patients with chronic hepatitis B virus (HBV) infection are at risk of developing hepatocellular carcinoma (HCC), and serum markers reflecting viral replication are potential predictors for HCC development. Besides the...

Review

June 16, 2021


Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Ho Soo Chun, A Reum Choe, Minjong Lee, et al.
Clin Mol Hepatol. 2021;27(4):535-552.

Although patients with cirrhosis are known to be in a state of “rebalance” in that pro- and anticoagulant factors increase the risk for both bleeding and thrombosis, the prevalence of...

Review

June 8, 2021


Recent advances in nonalcoholic fatty liver disease metabolomics
Hwi Young Kim
Clin Mol Hepatol. 2021;27(4):553-559.

The clinical phenotypes of nonalcoholic fatty liver disease (NAFLD) encompass from simple steatosis to nonalcoholic steatohepatitis (NASH) with varying degrees of fibrosis or cirrhosis. Liver biopsy has been the standard...

Original Article

August 2, 2021


New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
Hideyuki Tamai, Jumpei Okamura
Clin Mol Hepatol. 2021;27(4):564-574.

Background/Aims: In July 2017, the Emprint™ next-generation microwave ablation system using thermosphere technology (Covidien, Boulder, CO, USA) was approved for use in Japan. This system can produce a predictable spherical...

Original Article

July 13, 2021


Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, et al.
Clin Mol Hepatol. 2021;27(4):575-588.

Background/Aims: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods: We included 107 patients with Child-Pugh...

Original Article

July 23, 2021


Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, et al.
Clin Mol Hepatol. 2021;27(4):589-602.

Background/Aims: This study aimed to investigate whether everolimus (EVR) affects long-term survival after liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). Methods: The data from 303 consecutive patients with HCC...

Original Article

September 8, 2021


Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
Kyeong Deok Kim, Ji Eun Lee, Jong Man Kim, et al.
Clin Mol Hepatol. 2021;27(4):603-615.

Background/Aims: Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo...
Current Issue
Volume 27(4); Oct 2021

This archive contains links to the full-text of all issues of Clin Mol Hepatol.

Current issue

Volume 27(4); October

All issues

Vol. 27
2021

v.27(1)
Jan 2021

v.27(2)
Apr 2021

v.27(3)
Jul 2021

v.27(4)
Oct 2021
Vol. 26
2020

v.26(1)
Jan 2020

v.26(2)
Apr 2020

v.26(3)
Jul 2020

v.26(4)
Oct 2020
Vol. 25
2019

v.25(1)
Mar 2019
v.25(2)
Jun 2019
v.25(3)
Sep 2019 		v.25(4)
Dec 2019
Vol. 24
2018

v.24(1)
Mar 2018
v.24(2)
Jun 2018
v.24(3)
Sep 2018
v.24(4)
Dec 2018
Vol. 23
2017

v.23(1)
Mar 2017
v.23(2)
Jun 2017
v.23(3)
Sep 2017
v.23(4)
Dec 2017
Vol. 22
2016

v.22(1)
Mar 2016
v.22(2)
Jun 2016
v.22(3)
Sep 2016
v.22(4)
Dec 2016
Vol. 21
2015

v.21(1)
Mar 2015
v.21(2)
Jun 2015
v.21(3)
Sep 2015
v.21(4)
Dec 2015
Vol. 20
2014

v.20(1)
Mar 2014
v.20(2)
Jun 2014
v.20(3)
Sep 2014
v.20(4)
Dec 2014
Vol. 19
2013

v.19(1)
Mar 2013
v.19(2)
Jun 2013
v.19(3)
Sep 2013
v.19(4)
Dec 2013
The Korean Journal of Hepatology1995 (Vol.1 No.1) to 2012 (Vol.18 No.1)
Vol. 18
2012

v.18(1)
Mar 2012
v.18(2)
Jun 2012
v.18(3)
Sep 2012
v.18(4)
Dec 2012
Vol. 17
2011
v.17(1)
Mar 2011 		v.17(2)
Jun 2011 		v.17(3)
Sep 2011 		v.17(4)
Dec 2011
Vol. 16
2010
v.16(1)
Mar 2010 		v.16(2)
Jun 2010 		v.16(3)
Sep 2010 		v.16(4)
Dec 2010
Vol. 15
2009
v.15(1)
Mar 2009 		v.15(2)
Jun 2009 		v.15(3)
Sep 2009 		v.15(4)
Dec 2009 		v.15(60)
Dec 2009
Vol. 14
2008
v.14(1)
Mar 2008 		v.14(2)
Jun 2008 		v.14(3)
Sep 2008 		v.14(4)
Dec 2008
Vol. 13
2007
v.13(1)
Mar 2007 		v.13(2)
Jun 2007 		v.13(3)
Sep 2007 		v.13(4)
Dec 2007
Vol. 12
2006
v.12(1)
Mar 2006 		v.12(2)
Jun 2006 		v.12(3)
Sep 2006 		v.12(4)
Dec 2006
Vol. 11
2005
v.11(1)
Mar 2005 		v.11(2)
Jun 2005 		v.11(3)
Sep 2005 		v.11(4)
Dec 2005
Vol. 10
2004
v.10(1)
Mar 2004 		v.10(2)
Jun 2004 		v.10(3)
Sep 2004 		v.10(4)
Dec 2004
Vol. 9
2003
v.9(1)
Mar 2003 		v.9(2)
Jun 2003 		v.9(3)
Sep 2003 		v.9(4)
Dec 2003
Vol. 8
2002
v.8(1)
Mar 2002 		v.8(2)
Jun 2002 		v.8(3)
Sep 2002 		v.8(4)
Dec 2002
Vol. 7
2001
v.7(1)
Mar 2001 		v.7(2)
Jun 2001 		v.7(3)
Sep 2001 		v.7(4)
Dec 2001
Vol. 6
2000
v.6(1)
Mar 2000 		v.6(2)
Jun 2000 		v.6(3)
Sep 2000 		v.6(4)
Dec 2000
Vol. 5
1999
v.5(1)
Mar 1999 		v.5(2)
Jun 1999 		v.5(3)
Sep 1999 		v.5(4)
Dec 1999
Vol. 4
1998
v.4(1)
Mar 1998 		v.4(2)
Jun 1998 		v.4(3)
Sep 1998 		v.4(4)
Dec 1998
Vol. 3
1997
v.3(1)
Mar 1997 		v.3(2)
Jun 1997 		v.3(3)
Sep 1997 		v.3(4)
Dec 1997
Vol. 2
1996
v.2(1)
Jun 1996 		v.2(2)
Dec 1996
Vol. 1
1995
v.1(1)
Jun 1995

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

ABOUT
BROWSE ARTICLES
CURRENT ISSUE
FOR CONTRIBUTORS
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 569
TOTAL : 652486
Close layer